HAVCR2 and neoplasm: Strikingly, FLI1 deficiency within tumor cells culminated in decreased PD-1 and TIM-3 expression on CD8+ T cell surfaces, concomitant with increased IFN-γ and TNF-α release by CD8+ T cells (Fig. 1B–E).